OZOlga Ye. Zinovyeva

Olga Ye. Zinovyeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olga Ye. Zinovyeva has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • 5q spinal muscular atrophy in adults

    by D.A. Parastaeva, O.E. Zinovyeva, E.I. Safiulina, I.A. Strokov, K.A. Popovskaya

    Autosomal recessive spinal muscular atrophy (SMA), linked to chromosome 5q, is an orphan neuromuscular disease caused by mutations in the SMN1 gene (Survival Motor Neuron gene) on the long arm of chromosome 5. It is more common in males, especially at the onset of the disease in the interval from 37 months to 18 years. Since SMA is usually associated with rapid onset early in life, it is sometimes challenging to diagnose adolescents and adults as SMA symptoms are non-specific. Type IV SMA is uncommon. The onset of the disease can occur at the age of 15—50 years. The disease develops rather slowly, essentially with no effect on life duration. With this type of SMA, overall muscle strength gradually decreases, eventually causing the loss of the ability to move independently. We present our case of 5q SMA with the onset in adulthood.

  • Open Access

    Pregnancy vomiting obscuring other disease: a clinical case of Wernicke encephalopathy

    by Ekaterina A. Sinayskaya, Natalya S. Zemlina, Andrey V. Murashko, Olga E. Zinovieva, Dmitry E. Prokhorov, Прохоров Дмитрий Евгеньевич

    The article presents a clinical case of Wernicke encephalopathy occurring as complication of excessive pregnancy-related vomiting (hyperemesis gravidarum). This disorder has developed due to thiamine (vitamin B1) deficiency. The correct diagnosis is challenging due to the similarity of clinical manifestations with several other disorders. Timely diagnosis and early treatment reduce the risk of severe course and irreversible complications that can lead to the potentially adverse outcome. This case is remarkable due to the appearance of the disease in a 32-year-old pregnant woman with excessive vomiting. The patient demonstrated the classic symptom triad found in only 16% of patients with Wernicke encephalopathy. Primarily ataxia and nystagmus appeared, and later memory impairment with confabulations was recorded. Magnetic resonance imaging of the brain revealed bilateral symmetrical areas with increased MR signal intensity in T2 (SE and FLAIR) sequences in the mediodorsal nucleus (MD) of thalamus, subependymal microglia of the III ventricle, and periaqueductal gray. The treatment of Wernicke encephalopathy was immediately initiated with the use of intravenous thiamine 200 mg 3 times daily. The beneficial treatment effect was reported. Further pregnancy proceeded unremarkably and resulted in the birth of a live term girl. During the postpartum period, the patient reported persisting instability when walking, which increased with closed eyes, and non-systemic dizziness.


  • Open Access

    Characteristics of Patients with Hereditary Transthyretin Amyloid Polyneuropathy and Chronic Idiopathic Axonal Polyneuropathy in Russia: PRIMER Study Results

    by Natalya A. Suponeva, Olga E. Zinovieva, Fatima R. Stuchevskaya, Tatyana G. Sakovets, Darya A. Grishina, Maria S. Kazieva, Elvira I. Safiulina, Anton P. Soloviev, Evgenia A. Zorina, Саковец Татьяна Геннадьевна

    Introduction. Hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) is a severe progressive hereditary disease. Even with the availability of genetic testing for transthyretin (TTR) gene variants, timely hATTR-PN diagnosis remains challenging due to a great variability in its clinical presentation. Patients with hATTR-PN are often misdiagnosed with chronic idiopathic axonal polyneuropathy (CIAP). The objective of our study is to describe the baseline electrophysiological, clinical, and demographic characteristics of hATTR-PN and CIAP patients and to establish patients' pre-selection criteria for genetic testing. Materials and methods. Retrospective analysis was performed in 42 hATTR-PN patients and 58 CIAP patients (according to diagnosis defined in medical records from 1 January 2017 to 1 March 2024). Demographic, clinical, and electrophysiological data were collected at diagnosis. To identify factors influencing the likelihood of the hATTR-PN presence, a logistic regression model including clinically relevant variables was developed. Results. The mean age of hATTR-PN and CIAP patients was 57.7 and 60.9 years, respectively. As compared with CIAP patients, those with hATTR-PN more frequently exhibited gait disturbances (64.3% vs 37.9%), autonomic (47.6% vs 12.1%), cardiac (35.7% vs 10.3%) and gastrointestinal symptoms (64.3% vs 12.1%), unintentional weight loss (45.2% vs 12.1%), and heart failure with preserved ejection fraction (26.2% vs 6.9%). Peripheral nerve conduction scores were also lower in the hATTR-PN group. In predicting hATTR-PN, the logistic regression model had a sensitivity of 91% and a specificity of 97%. Conclusion. Demographic, clinical, and electrophysiological characteristics of patients with hATTR-PN and CIAP were described. Based on the screening data, it is feasible to predict hATTR-PN in CIAP patients with relatively high accuracy, sensitivity, and specificity.


  • Paraproteinemic neuropathies

    by O. E. Zinovyeva, D. K. Novikov, N. Z. Ochil-Zoda, V. V. Rameev

    Paraproteinemic polyneuropathies (PPN) occur generally infrequently and arise from diseases, associated with formation and accumulation of a pathological protein, commonly known as paraprotein, which is typically an immunoglobulin or its free light chain. Such diseases include the following: monoclonal gammopathy of undetermined significance, multiple myeloma, Waldenström’s macroglobulinemia, AL amyloidosis, POEMS syndrome, etc. Diagnosis of PPN is challenging due to nonspecific, indistinct or atypical clinical manifestation, and it is necessary to apply specialized laboratory methods, including immunochemical analysis of blood and urine. Moreover, medications can cause symptoms of polyneuropathy themselves. Thus, it is important to suspect the first symptoms of the disease in time, determine the mechanism of damage to nerve fibers, carry out differential diagnosis and initiate therapy targeting the suppression of pathological protein synthesis.


  • Landau–Kleff ner syndrome

    by E. V. Mandra, O. E. Zinovyeva, G. G. Toropina

    The article presents a long-term catamnestic observation (15 years) of a patient with Landau–Kleff ner syndrome (LCS), in its debut manifested by epileptic paroxysms, total aphasia, cognitive and behavioral impairment, on EEG spike-wave complexes. MRI in epileptic mode was without pathology. He received levetiracetam and hormone therapy (glucocorticosteroids, ACTH analogues) with regression of epileptic seizures and epileptic discharges on EEG and pronounced positive dynamics of speech and other cognitive functions. After 15 years, the patient had a confi dent cognitive defi cit, speech disorders were almost absent.

  • Treatment of patients with chronic nonspecific lumbalgia with various pain triggers

    by D.O. Rozhkov, O.E. Zinovyeva, A.M. Nosovsky, V.A. Parfenov

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка эффективности комплексной терапии у пациенток с хронической неспецифической люмбалгией, связанной с различными болевыми триггерами. МАТЕРИАЛ И МЕТОДЫ Обследована 121 пациентка с хронической неспецифической люмбалгией (средняя продолжительность боли 8,0±5,0 мес) в возрасте от 22 до 59 лет (средний возраст 42,1±10,5 года). В качестве болевых триггеров люмбалгии установлено поражение фасеточных суставов (24,8%), крестцово-подвздошного сочленения (23,2%), мышц (16,5%) или их комбинированное поражение (35,5%). Пациенткам проводилась комплексная терапия, включавщая лекарственные средства, кинезиотерапию и когнитивную терапию. До и после курса терапии (в среднем 3 нед) была проведена оценка интенсивности боли по цифровой рейтинговой шкале, ограничения жизнедеятельности (опросник Освестри), эмоционального состояния по госпитальной шкале тревоги и депрессии. РЕЗУЛЬТАТЫ После лечения отмечено снижение боли с 6,1±1,1 до 1,13±0,37 балла (pppp<0,01). Существенное улучшение состояния обнаружено при всех болевых триггерах хронической люмбалгии. В качестве достоверных предикторов низкой эффективности комплексной терапии отмечены большая длительность хронической люмбалгии, выраженность ограничений жизнедеятельности по опроснику Освестри и тревоги по госпитальной шкале тревоги и депрессии. ЗАКЛЮЧЕНИЕ Комплексная терапия, включающая лекарственные средства, кинезиотерапию и когнитивную терапию, эффективна при различных болевых триггерах хронической люмбалгии.


  • Open Access

    Cognitive functional therapy and non-steroidal anti-inflammatory drugs in the treatment of low back pain

    by O. E. Zinovyeva, A. A. Golovacheva

    A multidisciplinary approach including drug and non-drug methods is recommended for the treatment of chronic low back pain (CLBP). Kinesiotherapy, psychological methods, and nonsteroidal anti-inflammatory drugs (NSAIDs) have been shown to be highly effective for CLBP. All of the listed methods contribute to significant relief and relief of pain, increase the patient’s social and physical activity, and improve the emotional state. Psychological methods help patients cope with catastrophizing pain, increase daily activities, and reduce the likelihood of disease recurrence. Results from clinical studies and systematic reviews demonstrate the effectiveness of psychological techniques such as cognitive behavioral therapy (CBT) and mindfulness therapy (mindfulness) in the treatment of CLBP. Cognitive Functional Therapy (CFT) is a promising new psychological method that was created on the basis of CPT. Clinical studies have been conducted confirming the efficacy of CFT in CLBP. CFT is aimed at regular therapeutic exercises, normalization of motor activity with avoidance of excessive physical and static exertion, avoidance of sedentary lifestyle and normalization of sleep, which is often disturbed in chronic back pain. In practice, patients with CLBP often have low adherence to increased physical activity during the day, to therapeutic exercises. In most cases, this is due to the fact that in the first days of increased physical activity there is an increase in pain. Patients mistakenly fear further progression of pain and disease. Prescribing NSAIDs usually results in pain reduction as early as the first days of administration, so patients with chronic musculoskeletal pain have an increased desire to engage in physical activity and therapeutic exercises. The choice of a particular NSAID medication is made individually, taking into account the co-morbidities and the risk of possible side effects. We discuss the use of nimesulide in CLBP.


  • Open Access

    Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)

    by E. I. Safiulina, O. E. Zinovieva, N. S. Shcheglova, V. V. Rameev, Z. V. Surnina, E. N. Nikitina, O. A. Vorobieva

    Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)


  • The condition of the erector spinae muscle in patients with chronic nonspecific low back pain

    by D. O. Rozhkov, O. E. Zinovyeva, Н. В. Пеньков, A. D. Ulanova, S. S. Popova, G. Z. Mikhailova, I. M. Vikhlyantsev

    Myofascial pain syndrome caused by damage to the paravertebral muscles is considered as one of the causes of chronic back pain. At the same time, there is not enough information about the condition of the paravertebral muscles, and it is contradictory.The aim of the work is to elucidate the presence and severity of structural and functional changes in the paravertebral muscles and their role in the development of chronic nonspecific pain in the lower back in women.Material and methods. Morphological, immunohistochemical examination of a muscle tissue biopsy was performed in 17 patients aged 24 to 59 years (average age — 41.5 ± 12.1 years) with CNS (average duration of pain syndrome 10.0 ± 6.9 months) caused by myofascial pain syndrome, as well as determination by gel electrophoresis of the isoform composition of giant sarcomeric proteins titin and nebulin.Results. Morphological examination revealed no signs of necrosis, proliferation of connective and adipose tissue, inflammatory infiltration. The transformation of the myosin phenotype in the direction of an increase in the proportion of “fast” type II muscle fibers was revealed in the biopsies of the patients’ muscles. A decrease in the content of giant titin and nebulin proteins associated with myosin and actin in the sarcomere was also found.Conclusion. The data obtained indicate a violation of the contractile function of the paravertebral muscle in CNS.

  • Open Access

    Diabetic neuropathy in combination with deficiency state

    by O. E. Zinovyeva, P. D. Egorov, V. N. Novikov, I. M. Lovchev

    Diabetic polyneuropathy (DPN) is the most common neurological complication of diabetes mellitus. The most common type of DPN is distal symmetric, predominantly sensory, polyneuropathy. Chronic hyperglycemia plays a key role in DPN pathogenesis. It leads to accumulation of advanced glycation end products in tissues, including vasa nevrorum that supply peripheral nerves with oxygen. Thorough diagnostic approach to DPN is crucial for early detection of this condition. Early diagnosis and treatment slow DPN progression rates and leads to symptom reduction. Long-lasting metformin therapy may cause vitamin B deficiency. This article describes a comprehensive approach to the treatment of patient with type 2 diabetes and symptomatic diabetic and vitamin deficiency neuropathy. Apart from DM therapy, the patient received pathogenesis-based therapy of DPN with alpha-lipoic acid and a combination of vitamins B1, B6 and B12. Such pathogenesis-based approach has shown to decrease severity of DPN symptoms and reduce sensory ataxia.